Glaukos (GKOS) Change in Accured Expenses (2014 - 2026)
Glaukos' (GKOS) quarterly Change in Accured Expenses came in at -$10.2 million in Q1 2026, down 51.46% year-on-year from -$21.0 million in Q1 2025, and down 191.51% on a QoQ basis from $11.1 million in Q4 2025.
Glaukos (GKOS) Change in Accured Expenses (2014 - 2026) Analysis & Trends
Glaukos (GKOS) has 13 years of Change in Accured Expenses data on file, last reported at -$10.2 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 51.46% year-over-year to -$10.2 million in Q1 2026; TTM through Mar 2026 was $15.4 million, a 597.44% increase from a year earlier, with the FY2025 full-year figure at $18.8 million, up 89538.1% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$10.2 million, down from $11.1 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for GKOS reached as high as $15.9 million in Q2 2022 and fell as low as -$10.2 million in Q3 2022.
- Historically, Change in Accured Expenses has averaged $1.0 million across 5 years, with a median of $565000.0 in 2024.
- Across the five-year window, Change in Accured Expenses tumbled 421.62% in 2024 and jumped 1280.35% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $9.1 million in 2022, then slipped by 17.7% to $7.5 million in 2023, then tumbled by 40.61% to $4.4 million in 2024, then surged by 151.59% to $11.1 million in 2025, then sank by 191.51% to -$10.2 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were -$10.2 million in Q1 2026, $11.1 million in Q4 2025, and $7.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Glaukos | 8.83 Bn | 8.73 Bn | 117.23 Mn | -10.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10.19 Mn |
| Mar 31, 2026 | -10.19 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Dec 31, 2025 | 11.14 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Sep 30, 2025 | 7.80 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Jun 30, 2025 | 6.62 Mn |
| Mar 31, 2025 | -6.73 Mn |
| Mar 31, 2025 | -6.73 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Dec 31, 2024 | 4.43 Mn |
| Sep 30, 2024 | 565,000.00 |
| Sep 30, 2024 | 565,000.00 |
| Jun 30, 2024 | -1.35 Mn |
| Jun 30, 2024 | -1.35 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Mar 31, 2024 | -3.62 Mn |
| Dec 31, 2023 | 7.45 Mn |
| Dec 31, 2023 | 7.45 Mn |